TORSELLO, ANTONIO BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 15.595
AS - Asia 7.306
EU - Europa 6.751
SA - Sud America 996
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
Totale 30.802
Nazione #
US - Stati Uniti d'America 15.276
SG - Singapore 2.449
CN - Cina 1.808
IT - Italia 1.414
VN - Vietnam 1.207
DE - Germania 1.081
HK - Hong Kong 1.075
RU - Federazione Russa 1.020
BR - Brasile 817
SE - Svezia 675
IE - Irlanda 638
UA - Ucraina 623
GB - Regno Unito 382
CA - Canada 245
FI - Finlandia 228
AT - Austria 159
IN - India 156
FR - Francia 145
ID - Indonesia 114
KR - Corea 111
TR - Turchia 91
NL - Olanda 76
AR - Argentina 68
PL - Polonia 60
JP - Giappone 57
ZA - Sudafrica 57
BD - Bangladesh 55
BE - Belgio 52
DK - Danimarca 52
MX - Messico 51
IQ - Iraq 37
ES - Italia 31
EC - Ecuador 30
BG - Bulgaria 25
CO - Colombia 25
CH - Svizzera 21
CZ - Repubblica Ceca 18
UZ - Uzbekistan 16
KE - Kenya 15
PK - Pakistan 15
PY - Paraguay 15
EU - Europa 14
IR - Iran 13
SA - Arabia Saudita 13
MA - Marocco 12
VE - Venezuela 12
EG - Egitto 11
CL - Cile 10
LB - Libano 10
RO - Romania 10
TN - Tunisia 10
LT - Lituania 9
TW - Taiwan 9
IL - Israele 8
MY - Malesia 8
NP - Nepal 8
PE - Perù 8
UY - Uruguay 8
AU - Australia 7
PT - Portogallo 7
AZ - Azerbaigian 6
DZ - Algeria 6
EE - Estonia 6
JM - Giamaica 6
JO - Giordania 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
PH - Filippine 5
SC - Seychelles 5
SN - Senegal 5
AL - Albania 4
HU - Ungheria 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KG - Kirghizistan 3
BH - Bahrain 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
GE - Georgia 1
GH - Ghana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MD - Moldavia 1
Totale 30.796
Città #
Ann Arbor 2.635
Singapore 1.474
Woodbridge 1.350
Ashburn 1.275
Fairfield 1.171
Hong Kong 1.072
Houston 923
Chandler 917
Wilmington 834
Frankfurt am Main 740
Dublin 609
Jacksonville 581
Seattle 555
Milan 453
Beijing 378
Ho Chi Minh City 360
Cambridge 356
Dearborn 345
New York 333
Hanoi 290
Santa Clara 263
Princeton 260
Hefei 231
Dallas 229
Los Angeles 194
Nanjing 156
Vienna 138
Chicago 115
Lawrence 112
Shanghai 108
Moscow 106
Jakarta 103
Seoul 103
Altamura 98
Buffalo 97
Lachine 97
Helsinki 91
The Dalles 91
São Paulo 84
Council Bluffs 71
Boardman 68
Guangzhou 62
London 58
Detroit 57
San Diego 57
Rome 52
Munich 51
Brussels 49
Nanchang 48
Falls Church 47
Tokyo 44
Toronto 42
Da Nang 41
Kent 41
Nuremberg 41
Haiphong 39
Andover 37
Hebei 37
Warsaw 36
Changsha 34
Pune 32
Rio de Janeiro 32
Fremont 31
Mountain View 31
Shenyang 31
Grafing 30
Poplar 30
Denver 29
Dong Ket 29
Orem 29
Biên Hòa 28
Huizen 27
Brooklyn 25
Ha Long 25
Salt Lake City 25
Tianjin 24
Turku 24
Elora 23
San Francisco 23
Jiaxing 22
Jinan 22
Stockholm 22
Can Tho 21
Hangzhou 21
Monza 21
Ottawa 21
Philadelphia 21
Quận Bình Thạnh 21
Johannesburg 20
Kunming 20
Norwalk 20
Phoenix 20
Plovdiv 20
Atlanta 19
Columbus 19
Renton 18
Romola 18
Ankara 17
Redondo Beach 17
San Jose 17
Totale 21.284
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 477
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 452
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 435
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 423
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 414
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 410
Growth hormone secretagogues and the regulation of calcium signaling in muscle 403
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 400
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 351
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 349
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 330
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 322
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 312
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 310
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 302
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 302
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 301
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 274
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 271
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 270
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 269
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 266
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 262
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 260
Feeding behavior during long-term hexarelin administration in young and old rats 251
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 250
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 249
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 249
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 246
Intrarticular cytokines and resolvin after ACL and meniscal tear in skeletally immature patients 246
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 244
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 244
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 243
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 242
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 242
Ghrelin in gastroenteric pathophysiology 241
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 237
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 235
TLQP-21 modulate inflammation and fibrosis in a model of ards 234
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 233
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 230
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 230
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 229
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 227
Ghrelin regulates proliferation and differentiation of osteoblastic cells. 226
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis 225
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 224
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 223
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 222
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 221
Somatotropic dysregulation in old mammals 219
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 218
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 217
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 217
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 216
Somatostatin Withdrawal as Generator of Pulsatile GH Release in the Dog: A Possible Tool to Evaluate the Endogenous GHRH Tone? 216
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 215
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 215
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 212
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 212
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 211
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 211
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 209
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 209
Androgen therapy in neurodegenerative diseases 209
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 207
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 203
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 203
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 202
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 200
Progressive seizure aggravation in the repeated 6-Hz corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1/2 immunoreactivity in neurons 200
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 199
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 199
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 196
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 195
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 194
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection 194
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 194
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 193
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 193
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 192
Regulation of galanin by dexamethasone in the rat anterior pituitary and the uterus 192
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 191
Steroids and tissue-specific modulation of galanin gene expression in the male rat reproductive system 191
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 191
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 190
Growth hormone-inhibiting activity of cortistatin in the rat 189
Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat 189
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 187
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 186
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 185
Farmacologia endocrina 184
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 184
Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa 182
Modifications of plasma concentrations of hormonal and tissue factors during mechanical ventilation with positive end-expiratory pressure 180
Pyruvate and satiety: can we fool the brain? 180
Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? 180
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 179
Calcium signaling and secretory responses in agonist-stimulated pituitary gonadotrophs 178
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 178
Totale 24.194
Categoria #
all - tutte 101.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.652 0 0 0 0 0 227 234 229 236 298 186 242
2021/20221.905 149 182 233 139 100 178 85 70 109 172 152 336
2022/20233.507 375 937 375 361 290 505 43 184 211 38 109 79
2023/20242.045 75 91 93 103 281 500 419 74 132 34 38 205
2024/20255.037 270 458 361 309 429 236 360 267 333 692 401 921
2025/20267.294 1.812 1.058 972 1.394 1.451 607 0 0 0 0 0 0
Totale 31.395